Patents Assigned to Sulfagenix Inc

Treatment of viral infections

Patent number:  63/019,757 

Status: Application

Filed: May 04, 2020

Date of Patent: Pending

Assignee: Sulfagenix Inc

Inventors: Gabriel GOJON-ROMANILLOS, Gabriel GOJON-ZORRILLA

Preparation and compositions of zero-valent sulphur having high bioavailability, and uses thereof

Assignee: Sulfagenix Inc

Inventors: Gabriel GOJON-ROMANILLOS, Gabriel GOJON-ZORRILLA

Australia 

Patent number: AU2012321444B2

Status: Granted

Date of patent: 08 Oct 2015

European Patent Office

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

Germany

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

United Kingdom

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

Sweden

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

Mexico

Patent number: MX360050B

Status: Granted

Date of patent: 14 Nov 2018

China

Patent number: CN104080339B

Status: Granted

Date of patent: 28 Sep 2016

Australia

Patent number: AU2015210403B2

Status: Granted

Date of patent: 23 Mar 2017

Belgium

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

Spain

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

Italy

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

Hong Kong

Patent number: HK1200277A

Status: Pending

Date of patent: 24 Apr 2019

Japan
Patent number: JP5992525B2

Status: Granted

Date of patent: 14 Sep 2016

Canada
Patent number: CA2847589A1

Status: Granted

Date of patent: 18 Apr 2013

Switzerland

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

France

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

Netherlands

Patent number: EP2756757B1

Status: Granted

Date of patent: 24 Apr 2019

United States

Patent number: US8771755

Status: Granted

Date of patent: 08 Jul 2014

Brazil
Patent number: BR112014005144A2

Status: Pending

Date of patent: 18 Apr 2017

Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance

Assignee: Sulfagenix Inc

Inventors: Gabriel GOJON-ROMANILLOS

United States 

Patent number: US8389005

Status: Granted

Date of patent: 05 Mar 2013

United States 

Patent number: US8361514

Status: Granted

Date of patent: 29 Jan 2013

USA Address

3561 E Sunrise Dr, Ste 131

Tucson Arizona, USA 85718

Mexico Address

Av. Ricardo Margain 440, Torre Sofía Of. 602

San Pedro Garza García, Nuevo León, Mexico 66265

Terms

Privacy